CEO: Marisol Quintero

Advent Contact: Raj Parekh; Laura A. Lane

Bridging the innate to adaptive immune response

Bioncotech is a clinical-stage, immune-oncology company focused on developing a cutting-edge RNA-based therapies against validated and novel targets in cancer and immune cells

Back